Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JC.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JC.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.105NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.105NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.105NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.9.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.9.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-16947.8Singapore
XBB.1.9.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GJ.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.4.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.4.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.103NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.103NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.103NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HC.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HC.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HC.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FE.1.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FE.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FE.1.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.94NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.94NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.94NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.15.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.15.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GJ.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JS.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JS.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JS.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.2.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used